John Wilden, Global Health Futures on the state of curative healthcare both in the UK and US
Thursday, June 25, 2009 | Posted by: Grant Thornton
Categories:
Business,
Healthcare
| Tags: health,
john wilden,
global healthcare
“Global Healthcare Futures (GHF) is a UK company that is the brain child of John Wilden, a former specialist and consultant neurosurgeon. GHF is developing and promoting software products for “Time to Cure” and “Cost to Cure” Common Diseases based on the advances of molecular biology and other technologies which will underpin the fast looming world of curative global healthcare, thereby ushering in a new age of diminishing healthcare costs across the developed and developing world”.
Dr Tim Evans, Chairman of Global Health Futures
Reader Comments (1)
Embracing a tax friendly and investment/partnership model is an excellent suggestion. However, without dismantling the bloated bureaucracy plaguing Britain while restoring powers to the marketplace (the patients of the present and future) - many medical policies will still be politically influenced. This also exists in the U.S. Remember that 60% of America’s health care industry is a government program.
Added Fri Jul 2010 at 06:07:27